ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Cell Carcinoma
Renal Insufficiency
Carcinoma

Kidney Disease trials near Berlin, BE, DEU:

Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...

Enrolling
Chronic Kidney Disease With High Proteinuria
Drug: Dapagliflozin
Drug: Zibotentan/Dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 338 other locations

Locations recently updated

receptor is known to trigger injury and inflammation in the kidney and is therefore thought to play a role in CKD.Empagliflozin lowers blood...

Active, not recruiting
Chronic Kidney Disease
Type 2 Diabetes Mellitus
Drug: Finerenone (BAY94-8862 ) 20 mg
Drug: Finerenone Placebo

Phase 2

Bayer
Bayer

Berlin, Germany and 188 other locations

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling
Chronic Kidney Disease
Proteinuria
Drug: Finerenone (Kerendia, BAY94-8862)

Phase 3

Bayer
Bayer

Berlin, Germany and 144 other locations

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling
Chronic Kidney Disease
Proteinuria
Drug: Finerenone (Kerendia, BAY94-8862)
Drug: Placebo

Phase 3

Bayer
Bayer

Berlin, Germany and 116 other locations

performed thus far excluded patients with an eGFR below 25 mL/min/1.73m2 at inclusion, prevalent dialysis patients, and kidney transplant r...

Invitation-only
Kidney Failure
Kidney Disease, Chronic
Drug: Dapagliflozin 10 mg/day (oral)
Drug: Placebo

Phase 3

University Medical Center Groningen (UMCG)

Berlin, Germany and 64 other locations

(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...

Enrolling
Chronic Kidney Disease
Inflammation
Drug: Placebo (Ziltivekimab B)
Drug: Placebo (Ziltivekimab C)

Phase 3

Novo Nordisk
Novo Nordisk

Berlin, Germany and 950 other locations

The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This...

Enrolling
Chronic Kidney Disease and Hypertension
Drug: Baxdrostat/dapagliflozin
Drug: Dapagliflozin in combination with placebo

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 591 other locations

This study will look at how well a drug that reduced the amount of oxalate in the body works in patients that have kidney disease a ...

Enrolling
Chronic Kidney Disease Requiring Chronic Dialysis
Cardiovascular Disease
Drug: 0.9% Sodium Chloride (placebo)
Drug: Lumasiran

Phase 2

Charité University Medicine Berlin
Charité University Medicine Berlin

Berlin, Germany

of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...

Enrolling
Overweight and Obesity
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Berlin, Germany and 707 other locations

It is currently under development for the treatment of chronic kidney disease (CKD) and nonproliferative diabetic retinopathy (NPDR...

Enrolling
Chronic Kidney Disease
Non-proliferative Diabetic Retinopathy
Drug: BAY3283142
Drug: Placebo to BAY3283142

Phase 1

Bayer
Bayer

Berlin, Germany and 1 other location

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems